Literature DB >> 15756083

Pyridoxine in clinical toxicology: a review.

Philippe Lheureux1, Andrea Penaloza, Mireille Gris.   

Abstract

Pyridoxine (vitamin B6) is a co-factor in many enzymatic pathways involved in amino acid metabolism: the main biologically active form is pyridoxal 5-phosphate. Pyridoxine has been used as an antidote in acute intoxications, including isoniazid overdose, Gyromitra mushroom or false morrel (monomethylhydrazine) poisoning and hydrazine exposure. It is also recommended as a co-factor to improve the conversion of glyoxylic acid into glycine in ethylene glycol poisoning. Other indications are recommended by some sources (for example crimidine poisoning, zipeprol and theophylline-induced seizures, adjunct to d-penicillamine chelation), without significant supporting data. The value of pyridoxine or its congener metadoxine as an agent for hastening ethanol metabolism or improving vigilance in acute alcohol intoxication is controversial. This paper reviews the various indications of pyridoxine in clinical toxicology and the supporting literature. The potential adverse effects of excessive pyridoxine dosage will also be summarized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756083     DOI: 10.1097/00063110-200504000-00007

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  20 in total

Review 1.  Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes.

Authors:  D Nicholas Bateman; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2015-10-24       Impact factor: 4.335

2.  Status epilepticus due to attempted suicide with isoniazid.

Authors:  Daniel Tibussek; Ertan Mayatepek; Felix Distelmaier; Thorsten Rosenbaum
Journal:  Eur J Pediatr       Date:  2005-10-07       Impact factor: 3.183

3.  Pyridoxine toxicity courtesy of your local health food store.

Authors:  C D Silva; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 4.  Treatment of drug-induced seizures.

Authors:  Hsien-Yi Chen; Timothy E Albertson; Kent R Olson
Journal:  Br J Clin Pharmacol       Date:  2015-09-17       Impact factor: 4.335

Review 5.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

Review 6.  Mycetism: a review of the recent literature.

Authors:  Kimberlie A Graeme
Journal:  J Med Toxicol       Date:  2014-06

Review 7.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

Review 8.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

9.  Nutritional therapies in Parkinson's disease.

Authors:  Marian L Evatt
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

10.  B6 and Bleeding: A Case Report of a Novel Vitamin Toxicity.

Authors:  Alexandra J Borst; Dmitry Tchapyjnikov
Journal:  Pediatrics       Date:  2018-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.